Cargando…

Therapeutic Benefit of Galectin-1: Beyond Membrane Repair, a Multifaceted Approach to LGMD2B

Two of the main pathologies characterizing dysferlinopathies are disrupted muscle membrane repair and chronic inflammation, which lead to symptoms of muscle weakness and wasting. Here, we used recombinant human Galectin-1 (rHsGal-1) as a therapeutic for LGMD2B mouse and human models. Various redox a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vallecillo-Zúniga, Mary L., Poulson, Peter Daniel, Luddington, Jacob S., Arnold, Christian J., Rathgeber, Matthew, Kartchner, Braden C., Hayes, Spencer, Gill, Hailie, Valdoz, Jonard C., Spallino, Jonathan L., Garfield, Seth, Dodson, Ethan L., Arthur, Connie M., Stowell, Sean R., Van Ry, Pam M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621416/ https://www.ncbi.nlm.nih.gov/pubmed/34831431 http://dx.doi.org/10.3390/cells10113210

Ejemplares similares

Treatment with galectin-1 improves myogenic potential and membrane repair in dysferlin-deficient models
por: Vallecillo-Zúniga, Mary L., et al.
Publicado: (2020)

The Sweet-Side of Leukocytes: Galectins as Master Regulators of Neutrophil Function
por: Robinson, Brian S., et al.
Publicado: (2019)

An Improved Scalable Hydrogel Dish for Spheroid Culture
por: Valdoz, Jonard Corpuz, et al.
Publicado: (2021)

The ECM: To Scaffold, or Not to Scaffold, That Is the Question
por: Valdoz, Jonard Corpuz, et al.
Publicado: (2021)

Whole microbe arrays accurately predict interactions and overall antimicrobial activity of galectin-8 toward distinct strains of Streptococcus pneumoniae
por: Wu, Shang-Chuen, et al.
Publicado: (2023)

Spatially and optically tailored 3D printing for highly miniaturized and integrated microfluidics
por: Sanchez Noriega, Jose L., et al.
Publicado: (2021)

LGMD. Identification, description and classification
por: Angelini, Corrado
Publicado: (2020)

Disease Progression and Mutation Pattern in a Large Cohort of LGMD R1/LGMD 2A Patients from India
por: Ganaraja, Valakunja H., et al.
Publicado: (2021)

LGMD2I in a North American population
por: Kang, Peter B, et al.
Publicado: (2007)

Tail properties and approximate distribution and expansion for extreme of LGMD
por: Huang, Jianwen, et al.
Publicado: (2017)

PROCEEDINGS OF LGMD days MEETING: Prognosis and Treatment in LGMD October 15-17, 2014 IRCCS "S. Camillo", Lido di Venezia (VE), Italy
Publicado: (2014)

The role of galectins in immunity and infection
por: Liu, Fu-Tong, et al.
Publicado: (2023)

A Journey with LGMD: From Protein Abnormalities to Patient Impact
por: Georganopoulou, Dimitra G., et al.
Publicado: (2021)

Current and Future Approaches to Classify VUSs in LGMD-Related Genes
por: Li, Chengcheng, et al.
Publicado: (2022)

Innate immune Galectin-7 specifically targets microbes that decorate themselves in blood group-like antigens
por: Wu, Shang-Chuen, et al.
Publicado: (2022)

Lithium chloride corrects weakness and myopathology in a preclinical model of LGMD1D
por: Findlay, Andrew R., et al.
Publicado: (2019)

The sensitivity of exome sequencing in identifying pathogenic mutations for LGMD in the United States
por: Reddy, Hemakumar M., et al.
Publicado: (2016)

Mutational spectrum of Chinese LGMD patients by targeted next-generation sequencing
por: Yu, Meng, et al.
Publicado: (2017)

Genetic Counseling and NGS Screening for Recessive LGMD2A Families
por: Strafella, Claudia, et al.
Publicado: (2020)

Enhancing LGMD-based model for collision prediction via binocular structure
por: Zheng, Yi, et al.
Publicado: (2023)

Full-Length Galectin-3 Is Required for High Affinity Microbial Interactions and Antimicrobial Activity
por: Wu, Shang-Chuen, et al.
Publicado: (2021)

Natural history of LGMD2A for delineating outcome measures in clinical trials
por: Richard, Isabelle, et al.
Publicado: (2016)

Diagnostically important muscle pathology in DNAJB6 mutated LGMD1D
por: Sandell, Satu, et al.
Publicado: (2016)

Muscle involvement in limb-girdle muscular dystrophy with GMPPB deficiency (LGMD2T)
por: Oestergaard, S.T., et al.
Publicado: (2016)

Genotypic and Phenotypic Heterogeneity of LGMD1D due to DNAJB6 Mutations
por: Finsterer, Josef
Publicado: (2018)

Distance and Character-Based Evaluation of the V4 Region of the 18S rRNA Gene for the Identification of Diatoms (Bacillariophyceae)
por: Luddington, Ian A., et al.
Publicado: (2012)

The Many Roles of Galectin-3, a Multifaceted Molecule, in Innate Immune Responses against Pathogens
por: Díaz-Alvarez, Laura, et al.
Publicado: (2017)

The Pivotal Role of Galectin-3 in Viral Infection: A Multifaceted Player in Host–Pathogen Interactions
por: Stojanovic, Bojana S., et al.
Publicado: (2023)

Next-Generation Sequencing Identifies Transportin 3 as the Causative Gene for LGMD1F
por: Torella, Annalaura, et al.
Publicado: (2013)

LGMD phenotype due to a new gene and dysferlinopathy investigated by next-generation sequencing
por: Angelini, Corrado I.
Publicado: (2015)

LGMD D2 TNPO3-Related: From Clinical Spectrum to Pathogenetic Mechanism
por: Costa, Roberta, et al.
Publicado: (2022)

Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy: A GRASP-LGMD study
por: Doody, Amy, et al.
Publicado: (2023)

An Automated Approach to Assess Relative Galectin-Glycan Affinity Following Glycan Microarray Analysis
por: Ho, Alex D., et al.
Publicado: (2022)

Human Galectin-1 Improves Sarcolemma Stability and Muscle Vascularization in the mdx Mouse Model of Duchenne Muscular Dystrophy
por: Wuebbles, Ryan D., et al.
Publicado: (2019)

A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome
por: Blandin, Gaëlle, et al.
Publicado: (2013)

Redox State and Mitochondrial Respiratory Chain Function in Skeletal Muscle of LGMD2A Patients
por: Nilsson, Mats I., et al.
Publicado: (2014)

RNAi-mediated Gene Silencing of Mutant Myotilin Improves Myopathy in LGMD1A Mice
por: Liu, Jian, et al.
Publicado: (2014)

Next generation sequencing on patients with LGMD and nonspecific myopathies: Findings associated with ANO5 mutations
por: Savarese, Marco, et al.
Publicado: (2015)

The Author Reply: Genotypic and Phenotypic Heterogeneity of LGMD1D due to DNAJB6 Mutations
por: Kim, Kitae, et al.
Publicado: (2018)

Genetic landscape and novel disease mechanisms from a large LGMD cohort of 4656 patients
por: Nallamilli, Babi Ramesh Reddy, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_geb0b9k5kik9jmmoscc98augjo